Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
Status:
Completed
Trial end date:
2020-07-10
Target enrollment:
Participant gender:
Summary
This study aimed to investigate the efficacy of midodrine plus octreotide versus
norepinephrine and to determine the predictive factors of response in patients with HRS-AKI.
Phase:
Phase 4
Details
Lead Sponsor:
National Hepatology & Tropical Medicine Research Institute